Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Stehman-Breen
C. Stehman-Breen
Amgen
Physical therapy
Denosumab
Pharmacovigilance
Adverse effect
Medicine
2
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
AB0908 Findings From Denosumab (Prolia®) Postmarketing Safety Surveillance for Serious Infections
2015
Annals of the Rheumatic Diseases
W. Golden
D. Crittenden
M. Uhart
Rachel B. Wagman
C. Stehman-Breen
Socrates E. Papapoulos
Nelson B. Watts
Show All
Source
Cite
Save
Citations (3)
SAT0479 Early Findings from Prolia® Post-Marketing Safety Surveillance for Atypical Femoral Fracture, Osteonecrosis of the Jaw, Severe Symptomatic Hypocalcemia, and Anaphylaxis
2014
Annals of the Rheumatic Diseases
Michelle Geller
Rachel B. Wagman
Pei-Ran Ho
Suresh Siddhanti
C. Stehman-Breen
Nelson B. Watts
Socrates E. Papapoulos
Show All
Source
Cite
Save
Citations (15)
1